Skip to content

Efficacy of Pulsed Radiofrequency Combined with Stellate Ganglion Block in Acute Zoster-related Trigeminal Neuralgia with Pain Catastrophizing: A Retrospective Study

Efficacy of Pulsed Radiofrequency Combined with Stellate Ganglion Block in Acute Zoster-related Trigeminal Neuralgia with Pain Catastrophizing: A Retrospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099501
Enrollment
Unknown
Registered
2025-03-25
Start date
2025-02-05
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zoster-related Trigeminal Neuralgia

Interventions

Pulsed Radiofrequency (PRF) Group:None
Pulsed Radiofrequency Combined with Stellate Ganglion Block (PRF + SGB) Group:None

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1.Patients are diagnosed with herpes zoster-related trigeminal neuralgia, with a disease course of less than one month, specifically involving the first branch of the trigeminal nerve. 2.Conservative treatments have failed, including both pharmacological and physical therapies. 3.Pain Catastrophizing Scale (PCS) score is 30 or higher. 4.Visual Analog Scale (VAS) score is 5 or higher. 5.Age between 45 and 95 years old, with no gender restrictions.

Exclusion criteria

Exclusion criteria: 1.Presence of local ulcer infection. 2.Severe respiratory or cardiovascular failure, liver dysfunction, or renal insufficiency. 3.Known psychiatric disorders. 4.Coagulation disorders or currently receiving anticoagulant therapy. 5.History of substance abuse. 6.Previous exposure to other forms of invasive treatments, such as peripheral nerve electrical stimulation, trigeminal ganglion stimulation, or microballoon compression.

Design outcomes

Primary

MeasureTime frame
Degree of improvement in pain intensity;

Secondary

MeasureTime frame
Variations in pain catastrophizing levels;Improvements in sleep quality;Incidence of adverse reactions during treatment;

Countries

China

Contacts

Public ContactWu Chengwen

Affiliated Hospital of Southwest Medical University

1396550842@qq.com+86 15181401091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026